Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Marksans Pharma up 20...

    Marksans Pharma up 20 percent after inspection wind-up at Goa plant

    Written by supriya kashyap kashyap Published On 2017-02-21T11:05:27+05:30  |  Updated On 21 Feb 2017 11:05 AM IST
    Marksans Pharma up 20 percent after inspection wind-up at Goa plant

    New Delhi : Marksans Pharma zoomed 20 per cent after the company said inspection by the UK health regulator at its Goa plant has been completed without any critical observations.


    The stock skyrocketed 19.95 per cent to end at Rs 48.70 on BSE.


    On NSE, it soared 20 per cent to close at Rs 48.60.


    The company added Rs 332.36 crore to Rs 1,993.36 crore in market valuation.


    On the volume front, 92.82 lakh shares of the company were traded on the BSE and over 4 crore shares changed hands on the NSE during the day.


    The plant located at Verna has had an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14-17, Marksans Pharma said in a BSE filing.


    "The same has been completed without any critical observations," it added.


    The company, which makes formulations at the facility, is awaiting further instruction from the agency in this regard, Marksans Pharma said.

    critical observationinspectionMarksans PharmaMedicines and Healthcare Products Regulatory AgencyMHRAobservationUK Health Regulator
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok